Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-12-28

FDA Approved: BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE — Supplemental Application (LGM PHARMA SOLUTIONS, LLC)

View source ↗

Summary

The FDA approved a supplemental application for the generic combination product butalbital, acetaminophen, and caffeine from LGM PHARMA SOLUTIONS, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (butalbital; acetaminophen; caffeine)

Snippet

SUPPL AP for BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE (BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE)